I agree that this site is using cookies. You can find further informations here.
X
Pablo Alderuccio, Juan
83  results:
Search for persons X
?
1

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPD..:

Caimi, Paolo F ; Ai, Weiyun Z ; Pablo Alderuccio, Juan...
HemaSphere.  7 (2023)  S3 - p. e402511c , 2023
Link: https://doi.org/10.1097/..
 
?
2

Marginal zone lymphoma international prognostic index: a un..:

Arcaini, Luca ; Bommier, Côme ; Alderuccio, Juan Pablo...
eClinicalMedicine.  72 (2024)  - p. 102592 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Not all central nervous system lymphomas are created equal:

Alencar, Alvaro J. ; Alderuccio, Juan Pablo
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

Risk of transformation by frontline management in follicula..:

Florindez, Jorge ; Chihara, Dai ; Reis, Isildinha..
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
5

Transformation of Marginal Zone Lymphoma to Hodgkin Lymphom:

Moalem, Kamilia N ; Alderuccio, Juan Pablo ; Bommier, Côme...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
6

Impact of cumulative dose of brentuximab vedotin on outcome..:

Steiner, Raphael E. ; Hwang, Steven R. ; Khurana, Arushi...
Blood Advances.  7 (2023)  24 - p. 7485-7493 , 2023
Link: https://doi.org/10.1182/..
 
?
7

Quantitative PET-based biomarkers in lymphoma: getting read..:

Alderuccio, Juan Pablo ; Kuker, Russ A. ; Yang, Fei.
Nature Reviews Clinical Oncology.  20 (2023)  9 - p. 640-657 , 2023
Link: https://doi.org/10.1038/..
 
?
8

Outcomes of patients with limited‐stage plasmablastic lymph..:

Hess, Brian T. ; Giri, Anshu ; Park, Yeonhee...
American Journal of Hematology.  98 (2023)  2 - p. 300-308 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Loncastuximab tesirine in relapsed/refractory diffuse large..:

Caimi, Paolo F. ; Ai, Weiyun Z. ; Alderuccio, Juan Pablo...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
10

Clinical outcomes of older and younger patients treated wit..:

Hamadani, Mehdi ; Spira, Alexander ; Zhou, Xiaolei...
Blood Advances.  8 (2023)  1 - p. 93-98 , 2023
Link: https://doi.org/10.1182/..
 
?
11

Revised MALT‐IPI: A new predictive model that identifies hi..:

Alderuccio, Juan Pablo ; Reis, Isildinha M. ; Habermann, Thomas M....
American Journal of Hematology.  97 (2022)  12 - p. 1529-1537 , 2022
Link: https://doi.org/10.1002/..
 
?
12

Diffuse large B‐cell lymphoma of the Waldeyer's ring: A U.S..:

Florindez, Jorge A. ; Lossos, Izidore S. ; Alderuccio, Juan Pablo
Hematological Oncology.  41 (2022)  1 - p. 192-195 , 2022
Link: https://doi.org/10.1002/..
 
?
13

Long‐term outcomes of patients with conjunctival extranodal..:

Saul, Eduardo Edelman ; Alderuccio, Juan Pablo ; Reis, Isildinha M....
American Journal of Hematology.  98 (2022)  1 - p. 148-158 , 2022
Link: https://doi.org/10.1002/..
 
?
14

An international analysis evaluating frontline bendamustine..:

Alderuccio, Juan Pablo ; Arcaini, Luca ; Watkins, Marcus P....
Blood Advances.  6 (2022)  7 - p. 2035-2044 , 2022
Link: https://doi.org/10.1182/..
 
?
15

A Deep Learning-Aided Automated Method for Calculating Meta..:

Kuker, Russ A. ; Lehmkuhl, David ; Kwon, Deukwoo...
Cancers.  14 (2022)  21 - p. 5221 , 2022
Link: https://doi.org/10.3390/..
 
1-15